PTK2 and neoplasm: The enhancement of p53 degradation by FAK interaction with p53-MDM2 complex in the nuclear and perinuclear compartments may explain why the activity of p53, as a tumor suppressor, could be impaired in p53 wild-type (wt) tumors (such as neuroblastoma) despite its functional integrity [22].